Health Care & Life Sciences » Biotechnology | TBG Diagnostics Ltd.

TBG Diagnostics Ltd. | Balance Sheet

Fiscal year is January-December. All values AUD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
8,562.80
5,596.20
2,813.30
13,361.90
7,918.20
5,647
Total Accounts Receivable
1,577.70
1,211.60
785.30
696.10
2,126.80
620.10
Inventories
-
-
-
753.60
781.10
811.20
Other Current Assets
145.30
2,270.90
990.20
3,782.20
859.80
4,536.70
Total Current Assets
10,285.80
9,078.70
4,588.80
18,593.70
11,685.90
11,614.90
Net Property, Plant & Equipment
195.20
539.10
443.40
3,473.90
3,047.40
1,445.10
Total Investments and Advances
-
24.40
24.40
-
172.80
-
Long-Term Note Receivable
-
-
-
998.50
632.50
-
Intangible Assets
-
-
-
1,396.10
756.00
-
Other Assets
73.70
26.00
-
240.10
95.90
217.90
Total Assets
10,554.60
9,668.20
5,056.70
24,702.30
16,390.50
13,277.90
Accounts Payable
177.80
359.70
587.50
608.50
699.60
Other Current Liabilities
491.20
1,245.10
964.90
889.50
676.80
Total Current Liabilities
668.90
1,604.80
1,552.40
1,498.10
1,376.40
Provision for Risks & Charges
163.20
49.50
42.50
16.50
20.30
Total Liabilities
832.10
1,654.30
1,594.90
1,514.60
1,396.70
Common Equity (Total)
9,722.50
8,013.90
3,461.80
23,187.70
14,604.70
Total Shareholders' Equity
9,722.50
8,013.90
3,461.80
23,187.70
14,604.70
Total Equity
9,722.50
8,013.90
3,461.80
23,187.70
14,993.70
Liabilities & Shareholders' Equity
10,554.60
9,668.20
5,056.70
24,702.30
16,390.50
Accumulated Minority Interest
-
-
-
-
389.10

About TBG Diagnostics

View Profile
Address
101 Collins Street
Melbourne Victoria (VIC) 3000
Australia
Employees -
Website http://www.tbgbio.com
Updated 07/08/2019
TBG Diagnostics Ltd. engages in the research, development, and manufacture of biopharmaceuticals. It operates through the InVitro Diagnostics segment, which involves in the research of biological drugs and the retail and wholesale of veterinary drugs. The company was founded on September 26, 1989 and is headquartered in Melbourne, Australia.